Celator(R) Pharmaceuticals Announces
Appointment of Derek Miller as Chief Business Officer
December 3, 2013
November 25, 2013
InnoPharma Inc. Completes $20 Million Term Loan Facility
November 13, 2013
InnoPharma Inc. Appoints Vish Shetty as Vice President, Business Development & Alliance Management
November 11, 2013Celator(R) Pharmaceuticals Announces Listing on NASDAQ Under Symbol "CPXX"
November 7, 2013
Ocera
Therapeutics Announces $28 Million Private Placement
November 6, 2013
Zogenix Pursues Development Of Abuse
Deterrent Formulations Of Zohydro(TM) ER With Altus Formulation
Zogenix Receives FDA
Approval for Zohydro(TM) ER (hydrocodone bitartrate) Extend-Release Capsules
Auspex Appoints Pratik Shah
As CEO And Expands Executive Team
CASMED Announces Initial Sales
Of The Next-Generation FORE-SIGHT ELITE Cerebral Oximeter
Celator® Pharmaceuticals Announces Listing
On OTCBB And OTC Link
Jeryl L. Hilleman Joins Ocera Therapeutics
As Chief Financial Officer
Celator® Pharmaceuticals Receives U.S. Patent
On Proprietary Liposome Composition
Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch + Lomb
Celator® Pharmaceuticals Appoints Michael R. Dougherty
To Board Of Directors
Ocera Therapeutics Announces Completion
Of Merger With Tranzyme
Auspex Initiates Phase 3 Trial of SD-809
In Huntington's Disease
CASMED Receives FDA Clearance for Next-Generation Vital Signs Monitor
And Blood Pressure Solution
Valeant Pharmaceuticals International, Inc.
To Acquire Bausch + Lomb For $8.7 Billion
Packaging Coordinators, Inc. Acquires AndersonBrecon
From AmerisourceBergen
Zogenix Reports Positive Top-Line Results From Extended Relday(™) Phase 1 Clinical Trial
Celator® Pharmaceuticals Raises $32.5 Million Completing A $39.3 Million Private Placement Financing
Tranzyme Pharma And Ocera Therapeutics Announce Merger Agreement
CASMED Announces FDA Approval
Of Next Generation FORE-SIGHT® Absolute Tissue Oximeter
Torax Medical's LINX® Reflux Management System Featured
On USA Today
Bausch + Lomb Files Registration Statement
For Proposed Initial Public Offering
InnoPharma Inc. Announces Launch
Of Generic Cidofovir Injection In The United States
Vertiflex, Inc. Announces FDA Clearnace of Two Key Additions to Technology Portfolio January 8, 2013
Tranzyme Pharma Annunces Successful Completion of Drug Discovery Collaboration With Bristol-Myers Squibb January 4, 2013
Zogenix Reports Positive Results From Reiday (™) Phase 1 Clinical Trial January 3, 2013
Celator®
Pharmaceuticals Announces Appointment Of Fred Powell As Chief Financial
Officer
Tranzyme Pharma Announces Top-Line Results
Of TZP-102 Phase 2b Trial
Auspex Pharmaceuticals Closes $25 Million Series D Financing
Thomas, McNerney & Partners Invests
In Keystone Dental, Inc.
Cebix Announces Positive Results of ERSATTA Phase 1/2 Trial In Peripheral Neuropathy
Mallinckrodt Completes Acquisition
Of CNS Therapeutics, Inc.
Mallinckrodt Announces Definitive Agreement to Acquire CNS Therapeutics, Inc.
Torax Medical Secures $30M Financing
To Commercialize Pioneering Treatment For Reflux Disease
Torax Medical Names Veteran Industry Executive
To Lead Global Commercialization Effort
BMO Capital Markets: Flash: Tranzyme Pharma 2Q12 Recap Highlights Progress
In Diabetic Gastroparesis
Locus Development, Inc. Merges
With InVitae Division Of Genomic Health
Zogenix Begins Relday(TM) Clinical Trial
For Schizophrenia
July 12, 2012
AxioMed Spine Corporation Receives CE Mark
For Freedom® Cervical Disc
FDA Approves LINX®
System For The Treatment Of Reflux Disease
VertiFlex®, Inc. Completes Enrollment
of The Superion® Pivotal IDE Clinical Trial
December 13, 2011
Momenta Pharmaceuticals
Acquires Assets From Virdante Pharmaceuticals
December 5, 2011
InnoPharma Completes $15
Million Series A Financing
December 1, 2011
Zogenix Reports Positive
Phase 3 Results for Zohydro -- Meets Primary Efficacy Endpoint
August 17, 2011
Zogenix and DURECT Announce
Development and License Agreement for Antipsychotic Product Candidate
July 12, 2011
Zogenix Enters $30 Million
Royalty Financing Agreement with Cowen Healthcare Royalty Partners II
June 30, 2011
Cebix Initiates Phase 1b
Clinical Trial with Drug Candidate Ersatta™
June 16, 2011
CASMED Raises $15 Million
in Private Placement
June 9, 2011
Asante Solutions Receives
FDA Clearance for Pearl™ Insulin Pump
May 17, 2011
Asante Solutions, Inc.
Receives CE Mark for Pearl™ Insulin Pump
April 12, 2011
Boston Scientific
Strengthens Structural Heart Product Portfolio by Completing Acquisition of
Atritech
March 3, 2011
Tranzyme Pharma
and Norgine Initiate Dosing in Phase 3 Pivotal Study of Novel Intravenous GI
Motility Drug Ulimorelin
February 23, 2011
Thomas, McNerney & Partners
Expands Team and Moves West Coast Office to San Diego
February 23, 2011
Zogenix Announces Completion of Enrollment in ZX002 Phase 3 Efficacy Study
February 10, 2011
VertiFlex®, Inc. Announces Financing and New Investment Partner
February 1, 2011
Thomas, McNerney & Partners Promotes Two Members of its Investment Team
January 25, 2011
Boston Scientific to Acquire Atritech
January 19, 2011
December 20, 2010
Celator® Pharmaceuticals Raises $20 Million in Series D Financing
September 1, 2010
Sandoz Completes Acquisition of Oriel Therapeutics, Strengthening Potential for Global Leadership in Respiratory
June 3, 2010
Sandoz to Acquire Oriel Therapeutics, Gaining Rights to Portfolio of Respiratory Products Targeting Asthma and COPD
April 19, 2010
Intuity Medical Closes $64 Million Series D Financing - One of The Largest Medical Device Funding Events of 2009
January 5, 2010
Virdante Pharmaceuticals Secures Funding to Improve Antibody-Based Therapeutics for Autoimmune and Inflammatory Disorders
October 29, 2009
Michael Demane Joins Thomas, McNerney & Partners as Senior Advisor
April 3, 2009
Atritech Completes $30 Million Financing
March 25, 2009
Thomas, McNerney & Partners Promotes Three Members of Its Investment Team
January 8, 2009
Arkal Medical, Inc. Secures $17.5 Million in Series B Financing
September 16, 2008
Amarin Announces Private Placement for Up to $60 Million
May 14, 2008
Ocera Therapeutics Closes $35.5 Million Series C Financing
February 20, 2008
Wuxi Pharmatech to Acquire Apptec Laboratory Services, Inc.
January 3, 2008
Oriel $23 Million Richer: Firm Brings New Chairman
November 19, 2007
Pfizer to Acquire Coley Pharmaceutical Group
November 16, 2007
Tranzyme Pharma Closes New $20 Million Financing
November 1, 2007
Thomas, McNerney & Partners Expands Team on East and West Coasts
October 17, 2007
Isis Pharmaceuticals and Thomas, McNerney & Partners Announce that the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions
October 16, 2007
Thomas, McNerney & Partners Invests in Asante Solutions Inc.
January 12, 2007
Softscope Medical Technologies, Inc. Completes $4 Million Series A Financing
December 13, 2006
Galil Medical, a Leader in Cryotherapy Solutions, Announces $52 Million Financing
December 11, 2006
Thomas, McNerney & Partners Invests in Neurotherapeutics Pharma, Inc.
December 6, 2006
Quinnova Pharmaceuticals, Inc. Completes $13.6 Million Series A Financing
November 28, 2006
Thomas, McNerney & Partners Closes $375 Million Life Science & Medical Technology Fund
September 6, 2006
Zogenix, Inc. Created Through Aradigm Asset Sale of Intraject® Needle-Free Technology
August 28, 2006
Thomas, McNerney & Partners Is Lead Investor in Osteobiologics, Acquired By Smith & Nephew
July 11, 2006
Ocera Therapeutics Raises $12 Million Series B Financing
July 10, 2006
Ocera Therapeutics, a New Gastrointestinal and Liver-Focused Company, Raises $14.5m in Series A Financing
January 17, 2006
Coley Pharmaceutical Group Sets Price for Initial Public Offering
August 10, 2005
Torax Medical Completes $10 Million Series B Financing
June 28, 2005
Tranzyme Pharma Completes US$32 Million Financing
May 13, 2005
Coley Pharmaceutical Group Files Registration Statement for Proposed Initial Public Offering
April 20, 2005
Pfizer, Coley Pharmaceutical Group Enter Into Exclusive Global License for the Development and Commercialization of Promune for Cancers
March 24, 2005
Axiomed Spine Corporation Secures $18 Million in Series B Financing
February 21, 2005
Thomas McNerney & Partners Invests in Leptos Biomedical, Inc.
December 13, 2004
Thomas, McNerney & Partners Announces Pratik Shah, Ph.D. as New Venture Partner in San Francisco Office
November 8, 2004
Coley Pharmaceutical Group Raises $25 Million in Private Financing
September 29, 2004
Thomas, McNerney & Partners Invests in Solstice Neurosciences, Inc.
July 7, 2004
Thomas, McNerney & Partners Invests in Clarus Therapeutics, Inc.
February 13, 2004
Thomas, McNerney & Partners Invests in Intuity Medical Inc.
December 23, 2003
Osteobiologics, Inc. Closes $9.2 Million Financing
October 3, 2003
Coley Pharmaceutical Group Announces $35 Million Private Financing
August 25, 2003
Thomas, McNerney & Partners, LLC, Raises $216 Million for Its Inaugural Health Care Private Equity Fund
May 6, 2003